Mingkai Lin, MD, PHD

Mingkai Lin, MD, PHD


2013.01-now         Department of Glaucoma, Zhongshan Ophthalmic Center, Sun Yat
-sen University,  Chief Doctor.
2003.12-2012.12   Department of Glaucoma, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Associate Chief Doctor.
1998.12-2003.12   Department of Glaucoma, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Doctor in Charge.
1990.07-1998.12   Department of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Assistant.


2009.07-2011.01   University of Oklahoma Health Science Center, Oklahoma City, the USA. Visiting Scholar.

2002.11-2003.10   School of Optometry, UC Berkeley, USA. Post-doctor. The Scripps Research Institute, San Diego, USA. Post-doctor.

1998.09-2001.06   Zhongshan Ophthalmic Center, Sun Yat-sen University, Ph.D student.
1995.09-1998.08   Zhongshan Ophthalmic Center, Sun Yat-sen University, Master degree
in medicine.

1984.09-1990.06   Department of Medicine, Sun Yat-sen University, Medical training.

Committed to glaucoma optic nerve protection, and anti-scarring after glaucoma surgery. Mainly study the role of hypoxia inducible factor-1 (HIF-1) factor and its pathway in glaucoma.

Representative publications

Title Journal title Year Rank
One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma.
Int Ophthalmol 2019 Corresponding
Investigation of Corneal Astigmatism in Chinese Patients With Primary Angle Closure Disease.
J Glaucoma 2018 Corresponding
Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
Diabetes 2013 3th
Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.
IOVS 2012 1st
Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
Diabetologia 2011 1st